Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,418 JPY | -2.39% | -1.87% | -5.38% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the past twelve months, EPS forecast has been revised upwards.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.38% | 2.27B | C+ | ||
+13.19% | 68.18B | C+ | ||
+6.73% | 25.78B | C+ | ||
+6.34% | 7.99B | B | ||
-2.79% | 7.88B | C | ||
-24.02% | 7.62B | B- | ||
+21.83% | 4.45B | B+ | ||
-2.28% | 3.89B | B- | ||
-3.51% | 3.82B | B | ||
+25.02% | 3.69B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 9987 Stock
- Ratings Suzuken Co., Ltd.